{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:07:14Z","timestamp":1789240034177,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82061138004"],"award-info":[{"award-number":["82061138004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472750"],"award-info":[{"award-number":["81472750"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12304319"],"award-info":[{"award-number":["12304319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04107-z","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T13:27:59Z","timestamp":1765200479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Salivary metabolic profile landscape for gastric cancer screening: a metabolomic approach"],"prefix":"10.1186","volume":"25","author":[{"given":"Chuyang","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Murtazt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6774-6868","authenticated-orcid":false,"given":"Hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-3045","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"3","key":"4107_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4107_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejso.2019.08.018","volume":"46","author":"Y Oh","year":"2020","unstructured":"Oh Y, Kim MS, Lee YT, Lee CM, Kim JH, Park S. Laparoscopic total gastrectomy as a valid procedure to treat gastric cancer option both in early and advanced stage: a systematic review and meta-analysis. Eur J Surg Oncol. 2020;46(1):33.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"4107_CR3","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s10120-018-0827-9","volume":"21","author":"Y Kano","year":"2018","unstructured":"Kano Y, Ohashi M, Hiki N, et al. Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center. Gastric Cancer. 2018;21(6):1024.","journal-title":"Gastric Cancer"},{"key":"4107_CR4","doi-asserted-by":"crossref","unstructured":"Shah SC, Canakis A, Peek RM Jr, Saumoy M. Endoscopy for gastric cancer screening is cost effective for Asian Americans in the United States. Clin Gastroenterol Hepatol. 2020;18(13):3026\u201339.","DOI":"10.1016\/j.cgh.2020.07.031"},{"issue":"5","key":"4107_CR5","doi-asserted-by":"publisher","first-page":"e0422","DOI":"10.1097\/HC9.0000000000000422","volume":"8","author":"YH Yeo","year":"2024","unstructured":"Yeo YH, Lee YT, Tseng HR, et al. Alpha-fetoprotein: Past, present, and future. Hepatol Commun. 2024;8(5):e0422.","journal-title":"Hepatol Commun"},{"key":"4107_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.biopha.2017.09.032","volume":"95","author":"M Abbas","year":"2017","unstructured":"Abbas M, Habib M, Naveed M, et al. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice. Biomed Pharmacother. 2017;95:1082\u201390.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4107_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/cancers12030695","volume":"12","author":"P Thanh Huong","year":"2020","unstructured":"Thanh Huong P, Gurshaney S, Thanh Binh N, et al. Emerging role of Circulating tumor cells in gastric cancer. Cancers (Basel). 2020;12(3):695.","journal-title":"Cancers (Basel)"},{"key":"4107_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107458","volume":"207","author":"A Campos-Carrillo","year":"2020","unstructured":"Campos-Carrillo A, Weitzel JN, Sahoo P, et al. Circulating tumor DNA as an early cancer detection tool. Pharmacol Ther. 2020;207:107458.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4107_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56.","journal-title":"Mol Cancer"},{"issue":"7","key":"4107_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202200130","volume":"6","author":"H Tian","year":"2022","unstructured":"Tian H, Ni Z, Lam SM, et al. Precise metabolomics reveals a diversity of aging-associated metabolic features. Small Methods. 2022;6(7):e2200130.","journal-title":"Small Methods"},{"issue":"6487","key":"4107_CR11","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","journal-title":"Science"},{"issue":"1","key":"4107_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"key":"4107_CR13","doi-asserted-by":"publisher","first-page":"118513","DOI":"10.1016\/j.lfs.2020.118513","volume":"262","author":"S Fattahi","year":"2020","unstructured":"Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. PI3K\/AKT\/mTOR signaling in gastric cancer: epigenetics and beyond. Life Sci. 2020;262:118513.","journal-title":"Life Sci"},{"issue":"1","key":"4107_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, et al. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8(1):198.","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"4107_CR15","doi-asserted-by":"publisher","first-page":"11943","DOI":"10.3390\/ijms231911943","volume":"23","author":"L Chen","year":"2022","unstructured":"Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y. Lactate-lactylation hands between metabolic reprogramming and immunosuppression. Int J Mol Sci. 2022;23(19):11943.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4107_CR16","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.3390\/ijms21165845","volume":"21","author":"A Bleve","year":"2020","unstructured":"Bleve A, Durante B, Sica A, et al. Lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad. Int J Mol Sci. 2020;21(16):5845.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4107_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-21-3114","volume":"28","author":"PL Triozzi","year":"2022","unstructured":"Triozzi PL, Stirling ER, Song Q, et al. Circulating immune Bioenergetic, Metabolic, and genetic signatures predict melanoma patients\u2019 response to Anti-PD-1 immune checkpoint Blockade. Clin Cancer Res. 2022;28(6):1192\u2013202.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"4107_CR18","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.3390\/cancers14133237","volume":"14","author":"A Zafeiriadou","year":"2022","unstructured":"Zafeiriadou A, Kollias I, Londra T, et al. Metabolism-Related gene expression in Circulating tumor cells from patients with early stage Non-Small cell lung cancer. Cancers (Basel). 2022;14(13):3237.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4107_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12935-022-02845-y","volume":"23","author":"P Poplawski","year":"2023","unstructured":"Poplawski P, Alseekh S, Jankowska U, et al. Coordinated reprogramming of renal cancer transcriptome, metabolome, and secretome associates with immune tumor infiltration. Cancer Cell Int. 2023;23(1):2.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4107_CR20","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun C, Wang A, Zhou Y, et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat Commun. 2023;14(1):2692.","journal-title":"Nat Commun"},{"key":"4107_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2023.102362","volume":"76","author":"M Planque","year":"2023","unstructured":"Planque M, Igelmann S, Ferreira Campos AM, et al. Spatial metabolomics principles and application to cancer research. Curr Opin Chem Biol. 2023;76:102362.","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"4107_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12936-020-03427-x","volume":"19","author":"E Aninagyei","year":"2020","unstructured":"Aninagyei E, Abraham J, Atiiga P, et al. Evaluating the potential of using urine and saliva specimens for malaria diagnosis in suspected patients in Ghana. Malar J. 2020;19(1):349.","journal-title":"Malar J"},{"issue":"6","key":"4107_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/hr.2012.6","volume":"35","author":"M Kawamura","year":"2012","unstructured":"Kawamura M, Ohmoto A, Hashimoto T, et al. Second morning urine method is superior to the casual urine method for estimating daily salt intake in patients with hypertension. Hypertens Res. 2012;35(6):611\u20136.","journal-title":"Hypertens Res"},{"issue":"4","key":"4107_CR24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/metabo13040498","volume":"13","author":"E Hyv\u00e4rinen","year":"2023","unstructured":"Hyv\u00e4rinen E, Kashyap B, Kullaa AM. Oral sources of salivary metabolites. Metabolites. 2023;13(4):498.","journal-title":"Metabolites"},{"issue":"23","key":"4107_CR25","doi-asserted-by":"publisher","first-page":"16603","DOI":"10.3390\/ijms242316603","volume":"24","author":"E Ferrari","year":"2023","unstructured":"Ferrari E, Gallo M, Spisni A, et al. Human serum and salivary metabolomes: diversity and closeness. Int J Mol Sci. 2023;24(23):16603.","journal-title":"Int J Mol Sci"},{"key":"4107_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21775\/cimb.037.047","volume":"37","author":"Q Li","year":"2020","unstructured":"Li Q, Ouyang X, Chen J, et al. A review on salivary proteomics for oral cancer screening. Curr Issues Mol Biol. 2020;37:47\u201356.","journal-title":"Curr Issues Mol Biol"},{"issue":"3","key":"4107_CR27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/odi.13591","volume":"27","author":"VL Kouznetsova","year":"2021","unstructured":"Kouznetsova VL, Li J, Romm E, Tsigelny IF. Finding distinctions between oral cancer and periodontitis using saliva metabolites and machine learning. Oral Dis. 2021;27(3):484\u201393.","journal-title":"Oral Dis"},{"issue":"1","key":"4107_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41368-023-00231-6","volume":"15","author":"P Dongiovanni","year":"2023","unstructured":"Dongiovanni P, Meroni M, Casati S, et al. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. Int J Oral Sci. 2023;15(1):27.","journal-title":"Int J Oral Sci"},{"issue":"3","key":"4107_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, et al. The emerging roles of circrnas in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4107_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-anchem-061020-123959","volume":"15","author":"T Nonaka","year":"2022","unstructured":"Nonaka T, Wong DTW. Saliva diagnostics. Annu Rev Anal Chem (Palo Alto Calif). 2022;15(1):107\u201321.","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"4107_CR31","doi-asserted-by":"publisher","first-page":"121338","DOI":"10.1016\/j.carbpol.2023.121338","volume":"322","author":"SY Hsiung","year":"2023","unstructured":"Hsiung SY, Deng SX, et al. Machine learning-based monosaccharide profiling for tissue-specific classification of Wolfiporia extensa samples. Carbohydr Polym. 2023;322:121338.","journal-title":"Carbohydr Polym"},{"issue":"10251","key":"4107_CR32","first-page":"635","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, et al. Gastric Cancer Lancet. 2020;396(10251):635\u201348.","journal-title":"Gastric Cancer Lancet"},{"key":"4107_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12885-022-09570-9","volume":"22","author":"M Koopaie","year":"2022","unstructured":"Koopaie M, Ghafourian M, Manifar S, et al. Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls. BMC Cancer. 2022;22:473.","journal-title":"BMC Cancer"},{"key":"4107_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40364-023-00524-2","volume":"11","author":"N Swarup","year":"2023","unstructured":"Swarup N, Cheng J, Choi I, et al. Multi-faceted attributes of salivary cell-free DNA as liquid biopsy biomarkers for gastric cancer detection. Biomark Res. 2023;11:90.","journal-title":"Biomark Res"},{"issue":"10","key":"4107_CR35","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1373\/clinchem.2018.290569","volume":"64","author":"F Li","year":"2018","unstructured":"Li F, Yoshizawa JM, Kim KM, et al. Discovery and validation of salivary extracellular RNA biomarkers for noninvasive detection of gastric cancer. Clin Chem. 2018;64(10):1513\u201321.","journal-title":"Clin Chem"},{"issue":"1","key":"4107_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-023-01715-z","volume":"22","author":"S Ma","year":"2023","unstructured":"Ma S, Zhou M, Xu Y, et al. Clinical application and detection techniques of liquid biopsy in gastric cancer. Mol Cancer. 2023;22(1):7.","journal-title":"Mol Cancer"},{"issue":"8","key":"4107_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.trecan.2023.04.008","volume":"9","author":"DD Shi","year":"2023","unstructured":"Shi DD, Savani MR, Abdullah KG, McBrayer SK. Emerging roles of nucleotide metabolism in cancer. Trends Cancer. 2023;9(8):624\u201335.","journal-title":"Trends Cancer"},{"issue":"10","key":"4107_CR38","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.4161\/auto.21228","volume":"8","author":"TC Lin","year":"2012","unstructured":"Lin TC, Chen YR, Kensicki E, et al. Autophagy: resetting glutamine-dependent metabolism and oxygen consumption. Autophagy. 2012;8(10):1477\u201393.","journal-title":"Autophagy"},{"issue":"14","key":"4107_CR39","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3390\/cancers13143541","volume":"13","author":"CL Chen","year":"2021","unstructured":"Chen CL, Hsu SC, Ann DK, Yen Y, Kung HJ. Arginine signaling and cancer metabolism. Cancers (Basel). 2021;13(14):3541.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"4107_CR40","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1111\/cas.16256","volume":"115","author":"K Nakane","year":"2024","unstructured":"Nakane K, Yagi K, Yajima S, et al. Salivary metabolomic biomarkers for esophageal and gastric cancers by liquid chromatography-mass spectrometry. Cancer Sci. 2024;115(9):3089\u201398.","journal-title":"Cancer Sci"},{"issue":"2","key":"4107_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24(2):230\u201341.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"4107_CR42","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","volume":"68","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, Zhu LL, Zhang M, et al. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2\u2009+\u2009signalling in a GABA-independent manner. Gut. 2019;68(11):1994\u20132006.","journal-title":"Gut"},{"key":"4107_CR43","doi-asserted-by":"publisher","first-page":"1091825","DOI":"10.3389\/fcimb.2023.1091825","volume":"13","author":"B Ni","year":"2023","unstructured":"Ni B, Kong X, Yan Y, et al. Combined analysis of gut Microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer. Front Cell Infect Microbiol. 2023;13:1091825.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"4107_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpha.2020.11.009","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen Z, Huang X, Gao Y, et al. Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation. J Pharm Anal. 2021;11(4):505\u201314.","journal-title":"J Pharm Anal"},{"key":"4107_CR45","doi-asserted-by":"publisher","first-page":"701487","DOI":"10.3389\/fphar.2021.701487","volume":"12","author":"M Liu","year":"2021","unstructured":"Liu M, Liu Y, Feng H, et al. Clinical significance of screening differential metabolites in ovarian cancer tissue and Ascites by LC\/MS. Front Pharmacol. 2021;12:701487.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4107_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40170-023-00319-x","volume":"11","author":"L Vidman","year":"2023","unstructured":"Vidman L, Zheng R, Bod\u00e9n S, Ribbenstedt A, Gunter MJ, Palmqvist R, Harlid S, Brunius C, Van Guelpen B. Untargeted plasma metabolomics and risk of colorectal cancer-an analysis nested within a large-scale prospective cohort. Cancer Metab. 2023;11(1):17.","journal-title":"Cancer Metab"},{"issue":"18","key":"4107_CR47","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.3390\/diagnostics13182996","volume":"13","author":"J Ito","year":"2023","unstructured":"Ito J, Lemus H, Wu T, Serum, Phosphorus. Serum Bicarbonate, and renal function in relation to liver CYP1A2 activity. Diagnostics (Basel). 2023;13(18):2996.","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"4107_CR48","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/bjc.1998.173","volume":"77","author":"GI Murray","year":"1998","unstructured":"Murray GI, Taylor MC, Burke MD, Melvin WT. Enhanced expression of cytochrome P450 in stomach cancer. Br J Cancer. 1998;77(7):1040\u20134.","journal-title":"Br J Cancer"},{"issue":"1","key":"4107_CR49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/s12967-022-03809-6","volume":"20","author":"F Bellerba","year":"2022","unstructured":"Bellerba F, Chatziioannou AC, Jasbi P, et al. Metabolomic profiles of Metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials. J Transl Med. 2022;20(1):629.","journal-title":"J Transl Med"},{"issue":"4","key":"4107_CR50","first-page":"377","volume":"11","author":"S Nowell","year":"2002","unstructured":"Nowell S, Sweeney C, Hammons G, et al. CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(4):377\u201383.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"4107_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1517\/14728222.2011.645805","volume":"16","author":"L Santarpia","year":"2012","unstructured":"Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):103\u201319.","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"4107_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1368-7646(03)00024-4","volume":"6","author":"MA Alaoui-Jamali","year":"2003","unstructured":"Alaoui-Jamali MA, Qiang H. The interface between erbb and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery. Drug Resist Updat. 2003;6(2):95\u2013107.","journal-title":"Drug Resist Updat"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04107-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04107-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04107-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:02:59Z","timestamp":1765443779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04107-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4107"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04107-z","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics of the study was approved by the ethics committee of Anhui Medical University (No. 20140141). All saliva samples and clinical information were collected with the informed consent of the patient. Clinical trials are conducted in strict accordance with the Declaration of Helsinki. Consent for publication: All patients agreed and signed informed consent. The clinical information presented in this study is anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and given their consent for this article to be published Competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}